INTS vs ROL
Intensity Therapeutics, Inc. Common stock (INTS) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
INTS does not have a complete income-statement cache yet.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
INTS currently screens at market cap $7.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the INTS and ROL stock pages for the full models.
Not investment advice.